Travere Therapeutics
Travere Therapeutics seeks a Director of Translational Immunology to provide scientific leadership for a late-stage clinical development program focused on rare kidney diseases. This role involves developing translational strategies, managing nonclinical research, and collaborating with cross-functional teams including Clinical Development, Regulatory, and Medical Affairs. The successful candidate will lead external scientific interactions and drive the evaluation of new therapeutic opportunities within the organization.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
3% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Director, Nonclinical and Translational Science
Amylyx Pharmaceuticals
Associate Director, Translational Research – Immunology
CSL Behring Australia
Principal Scientist, Translational Science Immunology
CSL Behring Australia
Senior Director (Senior Principal Scientist), Translational Medicine, Immunology
Merck & Co., Inc.
Translational Biologist
Isomorphic Labs
Director of Translational Sciences
Century Therapeutics